Xceleron

Germantown, United States Founded: 1997 • Age: 29 yrs Acquired By Pharmaron
Accelerator Mass Spectrometry is utilized by Xceleron for pharmaceutical analysis.
Request Access

About Xceleron

Xceleron is a company based in Germantown (United States) founded in 1997 was acquired by Pharmaron in January 2017.. Xceleron has raised $10.02 million across 5 funding rounds from investors including Pharmaron, Montgomery County Government and Albion Capital. Xceleron operates in a competitive market with competitors including Evelo Biosciences, PathogenDX, BioAgilytix, Advion and Omass, among others.

  • Headquarter Germantown, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.02 M (USD)

    in 5 rounds

  • Latest Funding Round
    $2.4 M (USD), Series C

    Feb 06, 2012

  • Investors
    Pharmaron

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Pharmaron

    (Jan 10, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Xceleron

Xceleron has successfully raised a total of $10.02M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $2.4 million completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series C — $2.4M
  • First Round

    (25 May 2005)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2012 Amount Series C - Xceleron Valuation

investors

Jan, 2010 Amount Series C - Xceleron Valuation

investors

Mar, 2007 Amount Grant - Xceleron Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Xceleron

Xceleron has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pharmaron, Montgomery County Government and Albion Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Tech and Offline focused Stage-Agnostic micro VC Firm investing in the UK
Founded Year Domain Location
Venture capital investments are managed by Albion Capital.
Founded Year Domain Location
Venture capital firm investing in European software scale-up companies
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Xceleron

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Xceleron

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Xceleron Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Xceleron

Xceleron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, PathogenDX, BioAgilytix, Advion and Omass, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
domain founded_year HQ Location
Provider of DNA-based pathogen testing kits
domain founded_year HQ Location
Large-molecule bioanalysis is provided for biologics and biosimilars development.
domain founded_year HQ Location
Microfluidics and mass spectrometry products are provided for clinical research.
domain founded_year HQ Location
Native mass spectrometry services for protein characterization are provided.
domain founded_year HQ Location
Analytical and quality assurance services are provided for diverse industries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Xceleron

Pharmaron Acquires Xceleron Inc.
Businesswire9 years ago

Frequently Asked Questions about Xceleron

When was Xceleron founded?

Xceleron was founded in 1997 and raised its 1st funding round 8 years after it was founded.

Where is Xceleron located?

Xceleron is headquartered in Germantown, United States.

Is Xceleron a funded company?

Xceleron is a funded company, having raised a total of $10.02M across 5 funding rounds to date.

What does Xceleron do?

Xceleron was founded in 1997 in Germantown, United States, as an analytical contract research organization focused on the pharmaceutical sector. Accelerator Mass Spectrometry technology is applied by the company to support preclinical and clinical drug development, enabling analysis of small samples for absolute bioavailability, pharmacokinetics, and tissue distribution studies. Acquisition by Pharmaron occurred in January 2017, integrating services into broader preclinical and clinical offerings.

Who are the top competitors of Xceleron?

Xceleron's top competitors include PathogenDX, Alderley Analytical and BioAgilytix.

Who are Xceleron's investors?

Xceleron has 7 investors. Key investors include Pharmaron, Montgomery County Government, Albion Capital, Solon Ventures, and Frog Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available